Sanofi-Aventis 2Q net profit up 4.9 percent on higher sales of key drugs

Sanofi-Aventis 2Q profit up 4.9 percent

PARIS — Pharmaceutical company Sanofi-Aventis said Wednesday its net profit rose 4.9 percent in the second quarter on stronger sales of its diabetes drug Lantus and blood thinners Lovenox and Plavix.

Full article »

Sanofi-Aventis Q2 net profit up 5 percent on higher sales of key drugs

Sanofi-Aventis Q2 profit up 5 percent

PARIS — Pharmaceutical company Sanofi-Aventis reported Wednesday a 5 percent increase in second-quarter net profit, due to stronger sales of its diabetes drug Lantus and blood thinners Lovenox and Plavix, which it predicted would boost full-year earnings.

Full article »

Drugmaker Sanofi-Aventis to close some research labs, review status of others in restructuring

Sanofi-Aventis to close some plants, restructure

PARIS — French drugmaker Sanofi-Aventis SA announces a major corporate restructuring on the heels of new safety concerns that could hurt sales of a key drug, its once-a-day insulin Lantus.

Full article »

Inflammatory protein responsible for obesity-linked diseases unveiled

WASHINGTON - An inflammatory factor-already implicated in causing several diseases, like pulmonary disease, lung cancer, and arthritis- may also have a role to play in insulin resistance linked with obesity, according to a study.

Full article »

Scientists applied artificial pancreas to type 1 diabetes patients successfully

Virginia researchers claimed to have created artificial pancreas clinical trials to test an individually-”prescribed” control algorithm, which regulates blood glucose levels in Type 1 diabetics. The computerized, subcutaneous system could one day transform the way Type 1 diabetics manage their disease.

Full article »

Januvia coupled with metformin effective in diabetes

Januvia, the diabetes drug by the Merck & Co is found to be effective in improving the blood sugar levels over two years of treatment when combined with the older drug metformin. New studies has shown the results in London. The study has been presented at the European Association for the Study of Diabetes annual conference in Rome.

Full article »

Gastric bypass surgery more effective to control diabetes

France based researchers have presented a new study to explain the difference between the lap-band surgery and gastric bypass surgery to reverse the symptoms of diabetes. They find that the changes in the intestine make all the difference in controlling the effects of diabetes.

Full article »

Protected by Comment Guard Pro